In a major clinical trial published in The New England Journal of Medicine , patients taking retatrutide lost an average of about 24% of their body weight after 48 weeks
Singh S, Bedoy A, Muftuoglu M, Li L, Okeleji O, Dipmoy N, Ostermann L, Veletic I, Pacheco C, Basyal M, Kim T, Garland KM, Angel M, Luther S, Rohde C, Andreeff M , Anand V
How do GLP1 medications work
Jetzt zum Newsletter anmelden Melde dich zum Newsletter an und erhalte stets die neusten Informationen zu unseren Produkten, Events und Athleten.
Liraglutide may be considered in people with BED primarily for weight loss, but current evidence does not support its use for binge remission
Figure 2 The main cause is oxidative stress by H